| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8833698 | Journal of the American College of Surgeons | 2018 | 29 Pages |
Abstract
Our preliminary data suggest a strong association between the IDO2 inactivating Y359Stop SNP and an increased risk of FPC when compared with the control group. Future studies will evaluate the value of IDO2 genotyping as a prognostic, early detection marker for pancreatic ductal adenocarcinoma and a predictive marker for novel immune checkpoint therapies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Avinoam MD, Alexander J. PhD, Joseph A. BA, Austin MD, Jordan M. MD, FACS, Theresa P. PhD, MPH, MSN, Harish MD, FACS, Charles J. MD, FACS, George C. PhD, Jonathan R. PhD,